DUORESP Spiromax 160 ug / 4.5 ug pdr inh 160 µg120

7680701930016 CH-70193 R03AK07 03.04.3.

Active substances:

Budesonidum Formoteroli fumaras dihydricus

No images available

Details

Product number
7019301
CPT
-
Packaging group
120
Unit
Einzeldose(n)
Composition
budesonidum 160 µg, formoteroli fumaras dihydricus 4.5 µg, lactosum monohydricum 5 mg, ad pulverem pro dosi.

Articles (1)

DuoResp Spiromax 160 ug / 4.5 ug, Pulver zur Inhalation
Pulver
120
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
budesonidum
160.0 UG Substance Wirkstoff (Principe actif)
formoteroli fumaras dihydricus
4.5 UG Substance Wirkstoff (Principe actif)
lactosum monohydricum
5.0 MG Substance HBESI

Authorization holder

Teva Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
70193
Drug name
DuoResp Spiromax, Pulver zur Inhalation
Galenic form
PULIN
ATC Code
R03AK07
Authorization status
Z
Dispensation category
B
First authorization
02/04/2026
Authorization expiration date
01/04/2031
IT number
03.04.3.
Domain
Human medicine
Field of application
Antiasthmatikum, COPD

Packaging details

Description (FR)
DUORESP Spiromax 160 ug / 4.5 ug pdr inh 160 µg120
Description (DE)
DUORESP Spiromax 160 ug / 4.5 ug Inh Plv 160 µg120
Market launch
08/09/2026
Narcotic (BTM)
No

Other packaging sizes

DUORESP Spiromax 160 ug/4.5 ug pdr inh 160µg 3x120
3 x 120 EINZ
GTIN: 7680701930023
View
DUORESP Spiromax 320 ug/9 ug pdr inh 320 µg 60
60 EINZ
GTIN: 7680701930030
View
Buy us a coffee Explore the data